Cogstate Ltd

Cogstate Ltd is a neuroscience solutions company specializing in digital cognitive assessment platforms for clinical research and healthcare. Founded in 1999, the company provides validated, computer-based cognitive testing tools designed to measure brain health across connected devices. Cogstate's offerings include digital cognitive assessments, remote assessment capabilities for decentralized clinical trials, endpoint data quality services (rater training and monitoring), and healthcare cognitive screening solutions for clinical care settings. The company supports biopharmaceutical companies and academic institutions in clinical trials across 100+ indications, serving researchers worldwide. With 25 years of expertise, Cogstate has administered over 2 million digital tests and completed 35,800+ rater trainings. The platform is culture-neutral and optimized for precision in pharmaceutical studies, early-phase safety assessments, and cognitive impairment evaluation across conditions including Alzheimer's disease, Parkinson's disease, schizophrenia, and concussion. Cogstate's solutions are applied in neurology, sports medicine, and pharmaceutical development.